Edwards Lifesciences (EW) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Edwards Lifesciences (EW) over the last 15 years, with Q4 2024 value amounting to $155.2 million.
- Edwards Lifesciences' Accumulated Depreciation & Amortization rose 710.84% to $155.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $155.2 million, marking a year-over-year increase of 710.84%. This contributed to the annual value of $155.2 million for FY2024, which is 710.84% up from last year.
- Per Edwards Lifesciences' latest filing, its Accumulated Depreciation & Amortization stood at $155.2 million for Q4 2024, which was up 710.84% from $144.9 million recorded in Q4 2023.
- Over the past 5 years, Edwards Lifesciences' Accumulated Depreciation & Amortization peaked at $155.2 million during Q4 2024, and registered a low of $24.5 million during Q1 2020.
- For the 4-year period, Edwards Lifesciences' Accumulated Depreciation & Amortization averaged around $107.8 million, with its median value being $139.6 million (2022).
- In the last 5 years, Edwards Lifesciences' Accumulated Depreciation & Amortization skyrocketed by 1893.2% in 2020 and then soared by 379.66% in 2023.
- Edwards Lifesciences' Accumulated Depreciation & Amortization (Quarter) stood at $74.6 million in 2020, then surged by 87.13% to $139.6 million in 2022, then rose by 3.8% to $144.9 million in 2023, then rose by 7.11% to $155.2 million in 2024.
- Its last three reported values are $155.2 million in Q4 2024, $144.9 million for Q4 2023, and $139.6 million during Q4 2022.